Millennium Management LLC increased its holdings in Cronos Group Inc. (NASDAQ:CRON - Free Report) by 23.7% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 840,374 shares of the company's stock after buying an additional 161,163 shares during the period. Millennium Management LLC owned about 0.22% of Cronos Group worth $1,698,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors also recently bought and sold shares of CRON. Thompson Davis & CO. Inc. acquired a new position in shares of Cronos Group during the fourth quarter worth $29,000. Tower Research Capital LLC TRC increased its position in shares of Cronos Group by 140.5% during the fourth quarter. Tower Research Capital LLC TRC now owns 13,726 shares of the company's stock worth $28,000 after purchasing an additional 8,019 shares in the last quarter. SBI Securities Co. Ltd. acquired a new position in shares of Cronos Group during the fourth quarter worth $30,000. Jones Financial Companies Lllp increased its position in shares of Cronos Group by 64.5% during the fourth quarter. Jones Financial Companies Lllp now owns 16,623 shares of the company's stock worth $34,000 after purchasing an additional 6,520 shares in the last quarter. Finally, Zacks Investment Management acquired a new position in shares of Cronos Group during the fourth quarter worth $38,000. Institutional investors own 8.71% of the company's stock.
Cronos Group Stock Performance
Shares of CRON stock remained flat at $1.93 during trading hours on Wednesday. The stock had a trading volume of 1,415,944 shares, compared to its average volume of 1,309,894. The business's fifty day moving average price is $1.87 and its 200 day moving average price is $1.93. The stock has a market cap of $743.86 million, a P/E ratio of -14.85, a price-to-earnings-growth ratio of 1.74 and a beta of 1.06. Cronos Group Inc. has a 1-year low of $1.60 and a 1-year high of $2.58.
Cronos Group (NASDAQ:CRON - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported $0.02 EPS for the quarter, beating the consensus estimate of $0.01 by $0.01. Cronos Group had a negative net margin of 42.65% and a negative return on equity of 2.56%. The company had revenue of $33.62 million for the quarter, compared to analyst estimates of $45.44 million. On average, equities research analysts forecast that Cronos Group Inc. will post -0.03 EPS for the current fiscal year.
About Cronos Group
(
Free Report)
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
Featured Articles
Before you consider Cronos Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.
While Cronos Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
